Real-world health care costs and resource utilization associated with mild cognitive impairment in the United States: A retrospective cohort study of commercial and Medicare data [0.03%]
美国轻度认知障碍患者的实际医疗成本和资源利用情况：商保和医保数据回顾队列研究
Feride H Frech,Gang Li,Timothy R Juday et al.
Feride H Frech et al.
Background: Mild cognitive impairment (MCI) is a transitional stage before Alzheimer disease and related dementias (ADRD). The link between AD and increased health care resource utilization (HCRU) and costs is well establ...
Costs of obesity, obesity-related complications, and weight loss in the United States: A systematic literature review [0.03%]
美国肥胖、与肥胖相关联的并发症和减肥的成本：系统文献回顾
Alison M Bjornson,Shelagh M Szabo,Bonnie M K Donato et al.
Alison M Bjornson et al.
Background: One hundred million American adults are living with obesity; 75% also have obesity-related complications. Related medical spending exceeds $261 billion dollars. A contemporary synthesis of evidence on the aver...
Terry Richardson,Susan Wescott,Ruchi Gupta et al.
Terry Richardson et al.
The use of biologics in food allergy management is an emerging area; therefore, guidance is required for payers to ensure appropriate access. AMCP Market Insights undertook a multiphase program to refine proposed actions from a previous pro...
AMCP Market Insights: Impact of the evolving understanding of multiple sclerosis and emerging treatment approaches on managed care [0.03%]
AMS市场洞察：多发性硬化症的不断发展的认识以及出现的治疗方法对医疗补助的影响
Bridget Flavin,Justin Bioc,Janna Evans et al.
Bridget Flavin et al.
Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS) and is associated with significant clinical and economic burden. Advancements in the understanding of the underlying biology of MS have important impl...
Implementation of a nonstatin prior authorization checklist for patients with hypercholesterolemia: In 2 community health care systems [0.03%]
社区卫生系统中用于高胆固醇患者的非他汀类药物的事先审批检查清单的实施：在两个社区医疗体系中的应用
Dana McCormick,Pam R Taub,Jeffrey Carter et al.
Dana McCormick et al.
Background: Health plans have acknowledged there is a significant unmet need to improve prior authorization (PA) processes to increase patient access to life saving nonstatin therapies. Outcomes from a series of regional ...
Health care resource utilization and costs in Medicare Advantage beneficiaries using glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter-2 inhibitors [0.03%]
医疗保险优势受益人使用胰高血糖素样肽-1受体激动剂与钠-葡萄糖共转运蛋白-2抑制剂的医疗保健资源利用和成本差异
Insiya B Poonawalla,Petir Abdal,Mary Hayes et al.
Insiya B Poonawalla et al.
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) or sodium-glucose cotransporter-2 inhibitors (SGLT2i) are recommended as first-line therapy for glycemic management for adults with type 2 diabetes and spec...
Advancing the conversation: 30 years of scholarship in managed care pharmacy [0.03%]
推动对话三十年来 Managed Care Pharmacy 的研究成果
Laura E Happe
Laura E Happe
This article commemorates the 30th anniversary of the Journal of Managed Care & Specialty Pharmacy (JMCP), reflecting on its evolution to a central voice in managed care pharmacy. Launched in 1995, JMCP has chronicled the profession's growt...
The effectiveness and value of suzetrigine for moderate to severe acute pain: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council [0.03%]
硫酸氢司来吉兰治疗中至重度急性疼痛的有效性和价值：来自临床与经济评价研究所中西部比较有效性公共咨询委员会的总结报告
Dmitriy Nikitin,David M Rind,Brett McQueen et al.
Dmitriy Nikitin et al.
Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease [0.03%]
与1型糖尿病和慢性肾病患者单用胰岛素治疗相比，索格列净的成本效益分析模型
Jaehong Kim,Shanshan Wang,Moises Marin et al.
Jaehong Kim et al.
Background: Patients with type 1 diabetes (T1D) have a greater than 50% lifetime risk of developing comorbid chronic kidney disease (CKD). Glycemic control can reduce diabetes-related complications and slow CKD progressio...
Changes in cost-related nonadherence among US adults with multiple chronic conditions from 2019 to 2023 [0.03%]
2019年至2023年美国多病共存成年人因费用相关因素未能遵从医嘱的变化趋势
Alejandro Amill-Rosario,Julia F Slejko,Susan dosReis
Alejandro Amill-Rosario
Background: Cost-related nonadherence (CRN), that is, not taking medication as prescribed to save money, may remain disproportionately high among individuals with multiple chronic conditions, particularly during periods o...